Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | FLT3 | P36888 | 5/20 | 0.54 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.53 |
| ▸ | AURKA | O14965 | 2/20 | 0.52 |
| ▸ | PRKAA1 | Q13131 | 6/20 | 0.48 |
| ▸ | PRKAA2 | P54646 | 5/20 | 0.48 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.48 |
| ▸ | CDK2 | P24941 | 2/20 | 0.48 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 5/20 | 0.48 |
| ▸ | TLK2 | Q86UE8 | 2/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 5/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.47 |
| ▸ | FLT1 | P17948 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6326979 | 0.89 | ALK (0.50) | ALKMEN1KMT2AFLT3RPS6KA3 | |
| SCHEMBL6328615 | 0.88 | KDR (0.49) | ALKMEN1KMT2AFLT3RPS6KA3 | |
| SCHEMBL6326803 | 0.88 | RET (0.56) | RPS6KA3CDK2KDRPDGFRBFGFR1 | |
| SCHEMBL6328765 | 0.88 | RET (0.56) | ALKMEN1KMT2ARPS6KA3CDK2 | |
| SCHEMBL6330154 | 0.87 | KDR (0.55) | ALKFLT3CDK2KDRPDGFRB | |
| SCHEMBL6328965 | 0.87 | KDR (0.58) | ALKMEN1KMT2AFLT3RPS6KA3 | |
| SCHEMBL6327563 | 0.86 | RET (0.58) | FLT3RPS6KA3AURKAPRKAA1CCNE1 | |
| SCHEMBL21916801 | 0.85 | ALK (0.69) | ALKMEN1KMT2AFLT3RPS6KA3 | |
| SCHEMBL6333700 | 0.84 | CDK2 (0.52) | ALKMEN1KMT2AFLT3AURKA | |
| SCHEMBL6330995 | 0.84 | ALK (0.43) | ALKMEN1KMT2AFLT3RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050032871-A1 | Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors | SUGEN, INC. | 2005-02-10 | — | — | US | claimed |
| US-20050032871-A1 | Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors | SUGEN, INC. | 2005-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050032871-A1 | Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors | MAP3K20, CDK20, STK10 | ALK 478/4885MEN1 3188/4885KMT2A 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.